Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Suppan, C.
Post San Antonio update-my top three abstracts!
MEMO-MAG EUR MED ONC. 2021;
Doi: 10.1007/s12254-021-00718-0
Web of Science
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Suppan Christoph
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Recent findings support the role of alpelisib in advanced HR-positive breast cancer harboring a PIK3CA mutation. A retrospective biomarker analysis on the intrinsic subtypes of HR-positive breast cancer reveals a subgroup that will not benefit under the addition of a CDK 4/6 inhibitor treatment. The detection of circulating tumor cells before start and during tumor treatment is associated with worse outcome in metastatic breast cancer patients.
- Find related publications in this database (Keywords)
-
Metastatic breast cancer
-
CDK 4
-
6 inhibitor
-
Endocrine resistance
-
PIK3CA mutations
-
Circulating tumor cells